These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22946345)

  • 1. Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
    Ohe M; Oshita F; Kenmotsu Y; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
    J Exp Ther Oncol; 2012; 10(1):65-9. PubMed ID: 22946345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
    Oshita F; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):345-50. PubMed ID: 23124649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer.
    Oshita F; Yamada K; Saito H; Noda K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):465-70. PubMed ID: 17960380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factors.
    Oshita F; Saito H; Yamada K
    J Exp Ther Oncol; 2007; 6(3):251-6. PubMed ID: 17552365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
    Oshita F; Yamada K; Kato Y; Ikehara M; Noda K; Tanaka G; Nomura I; Suzuki R; Saito H
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
    Kenmotsu Y; Oshita F; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
    Anticancer Res; 2012 Apr; 32(4):1453-6. PubMed ID: 22493385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer.
    Oshita F; Yamada K; Saito H; Noda K; Hamanaka N; Ikehara M
    J Exp Ther Oncol; 2004 Dec; 4(4):343-8. PubMed ID: 15844664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.
    Yamada K; Saito H; Kondo T; Murakami S; Masuda N; Yamamoto M; Igawa S; Katono K; Takiguchi Y; Iwasawa S; Kurimoto R; Okamoto H; Shimokawa T; Hosomi Y; Takagi Y; Kishi K; Ohba M; Oshita F; Watanabe K
    Anticancer Res; 2015 Dec; 35(12):6705-11. PubMed ID: 26637886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage
treatment in refractory or relapsed small cell lung cancer].
    Yu S; Wang Y; Hu X; Wang H; Hao X; Xu J; Li J; Zhang X; Shi Y
    Zhongguo Fei Ai Za Zhi; 2013 Sep; 16(9):470-5. PubMed ID: 24034994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.
    Choi HJ; Cho BC; Shin SJ; Cheon SH; Jung JY; Chang J; Kim SK; Sohn JH; Kim JH
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):309-13. PubMed ID: 17576560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer.
    Machida S; Ohwada M; Fujiwara H; Konno R; Takano M; Kita T; Kikuchi Y; Komiyama S; Mikami M; Suzuki M
    Oncology; 2003; 65(2):102-7. PubMed ID: 12931014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
    Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
    Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.
    Ohara T; Kobayashi Y; Yoshida A; Yoshioka N; Yahagi N; Kondo H; Tozawa A; Kiguchi K; Suzuki N
    Int J Clin Oncol; 2013 Dec; 18(6):1102-6. PubMed ID: 23095879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
    Miyamoto M; Takano M; Kuwahara M; Soyama H; Kato K; Matuura H; Sakamoto T; Takasaki K; Aoyama T; Yoshikawa T; Furuya K
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):111-117. PubMed ID: 29124328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.
    Oshita F; Honda T; Murakami S; Kondo T; Saito H; Noda K; Yamada K
    J Thorac Oncol; 2011 Jan; 6(1):128-31. PubMed ID: 21150472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301.
    Kobayashi M; Matsui K; Iwamoto Y; Ebi N; Oizumi S; Takeda K; Sawa T; Shibata K; Saka H; Imamura F; Seki N; Saito H; Goto I; Nakagawa K;
    J Thorac Oncol; 2010 Jul; 5(7):1075-80. PubMed ID: 20479694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined irinotecan (CPT-11) and nedaplatin (254-S) therapy for advanced and/or recurrent cervical cancer].
    Hiruma R; Kamide T; Anzai N; Matsumoto R; Kotake Y; Wachi T; Shinozaki H; Tada A; Kamiya N; Sasaki H
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):607-10. PubMed ID: 18408429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
    Tsavaris N; Ziras N; Kosmas C; Giannakakis T; Gouveris P; Vadiaka M; Dimitrakopoulos A; Karadima D; Rokana S; Papalambros E; Papastratis G; Margaris H; Tsipras H; Polyzos A
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):514-9. PubMed ID: 14504920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with irinotecan and cisplatin in elderly patients (>or= 65 years) with extensive-disease small-cell lung cancer.
    Kim HG; Lee GW; Kang JH; Kang MH; Hwang IG; Kim SH; Hahm JR; Jeong YY; Kim HC; Lee JD; Lee JS; Hwang YS
    Lung Cancer; 2008 Aug; 61(2):220-6. PubMed ID: 18272249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.